$91.96 -1.1% vs prev close
GMED Stock Price vs. AI Score Data gathered: January 27
3M 49.6%

AI Stock Analysis - Globus Medical (GMED)

Analysis generated January 9, 2026.

Globus Medical, Inc. is a leading medical device company that specializes in the design and development of products used in the treatment of musculoskeletal disorders. Founded in 2003, the company has grown to become a significant player in the spinal implant industry. Globus Medical's product portfolio includes a variety of solutions for minimally invasive surgeries and musculoskeletal augmentation. The company's commitment to innovation and quality has enabled it to maintain a strong market position.

Read full AI stock Analysis

Stock Alerts - Globus Medical (GMED)

company logo Globus Medical | January 13
Insider Alert: Kline Kyle is selling shares
company logo Globus Medical | January 9
Over the past few months, there has been an downward trend in Web Traffic.
company logo Globus Medical | January 8
Price is up by 11.5% in the last 24h.
company logo Globus Medical | January 7
Employee Rating is up by 3.7% over the last month.

Download our app to get future alerts delivered in real-time.

About Globus Medical

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally.


Globus Medical
Price $91.96
Target Price Sign up
Volume 1,180,000
Market Cap $12.5B
Year Range $51.89 - $94.64
Dividend Yield 0%
PE Ratio 29.94
Analyst Rating 71% buy
Industry Medical Devices

In the news


Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q3 '25769M282M487M119M215M1.180
Q2 '25745M249M497M203M193M0.860
Q1 '25598M195M403M75M164M0.680
Q4 '24657M263M394M27M145M0.840
Q3 '24626M271M355M52M116M0.830

Insider Transactions View All

Norwalk Leslie V filed to sell 10,419 shares at $101.1.
January 12 '26
Norwalk Leslie V filed to sell 12,419 shares at $88.9.
December 16 '25

FAQ - Globus Medical

The Market Cap of Globus Medical is $12.5B.

As of today, Globus Medical's PE (Price to Earnings) ratio is 29.94.

Currently, the price of one share of Globus Medical stock is $91.96.

The GMED stock price chart above provides a comprehensive visual representation of Globus Medical's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Globus Medical shares. Our platform offers an up-to-date GMED stock price chart, along with technical data analysis and alternative data insights.

As of our latest update, Globus Medical (GMED) does not offer dividends to its shareholders. Investors interested in Globus Medical should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.

Some of the similar stocks of Globus Medical are Boston Scientific, Edwards Lifesciences, Intuitive Surgical, Medtronic, and Stryker.

.
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.

Chat with AltIndex AI

👋 Welcome to AltIndex AI Chat!

Ask about:
  • Top Stocks
  • AI score insights
  • Trending investment opportunities
  • How to use AltIndex
You need to log in to use AltIndex AI Chat.
Disclaimer: AI outputs may be incorrect. This is for informational purposes only and not a substitute for professional financial advice.